{"schema_version":"alpha-profile-public-v1","slug":"james-culverwell","canonical_url":"https://registry.alpha.ac/people/james-culverwell","as_of":"2026-10-21T23:23:55.70284+00:00","published_at":"2026-09-02T02:37:24.239523+00:00","last_reviewed_at":"2026-05-16T07:20:49.178+00:00","identity":{"display_name":"James Culverwell","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Quoin Pharmaceuticals, Ltd.","company_slug":"quoin-pharmaceuticals-ltd","exchange":"NASDAQ","ticker":"QNRX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","effective_date":"2025-07-17","last_checked_at":"2026-04-28T23:00:07.354+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=james-culverwell","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=james-culverwell&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["CEO and Chairman of HOX Therapeutics since 2013. Founded Sudbrook Associates in 2005 and previously served as Senior Vice President at Merrill Lynch and Director of Healthcare Equity Research at ABN Amro Bank."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Quoin Pharmaceuticals, Ltd.","organizationId":"quoin-pharmaceuticals-ltd","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Quoin Pharmaceuticals, Ltd.","company_slug":"quoin-pharmaceuticals-ltd","exchange":"NASDAQ","ticker":"QNRX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","effective_date":"2025-07-17","last_checked_at":"2026-04-28T23:00:07.354+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for James Culverwell as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.459224+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for James Culverwell as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T07:20:49.37788+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","published_at":"2026-03-26T00:00:00+00:00","last_checked_at":"2026-05-16T07:20:49.235673+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"James Culverwell currently serves as Director at Quoin Pharmaceuticals, Ltd..","claim_state":"verified","valid_from":"2025-07-17","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.426793+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"James Culverwell serves on Audit, Compensation.","claim_state":"verified","valid_from":"2025-07-17","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.443338+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"HOX Therapeutics","claim_text":"James Culverwell is linked to HOX Therapeutics as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.55969+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"James Culverwell is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.542845+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for James Culverwell as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.491774+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for James Culverwell as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T07:20:49.41037+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","published_at":"2026-03-26T00:00:00+00:00","last_checked_at":"2026-05-16T07:20:49.235673+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Quoin Pharmaceuticals, Ltd.","claim_text":"James Culverwell is associated with Quoin Pharmaceuticals, Ltd..","claim_state":"verified","valid_from":"2026-03-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T07:20:49.362091+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","published_at":"2026-03-26T00:00:00+00:00","last_checked_at":"2026-05-16T07:20:49.235673+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Director","claim_text":"James Culverwell is listed as Director at Quoin Pharmaceuticals, Ltd..","claim_state":"verified","valid_from":"2026-03-26","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T07:20:49.340934+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","published_at":"2026-03-26T00:00:00+00:00","last_checked_at":"2026-05-16T07:20:49.235673+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Chief Executive Officer and Chairman","company":"HOX Therapeutics"},"claim_text":"James Culverwell is also linked to HOX Therapeutics as Chief Executive Officer and Chairman.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T07:20:49.453159+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","published_at":"2026-03-26T00:00:00+00:00","last_checked_at":"2026-05-16T07:20:49.235673+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for James Culverwell as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T02:04:43.47523+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","published_at":"2025-07-17T00:00:00+00:00","last_checked_at":"2026-05-16T02:04:43.346199+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":true,"claim_text":"Executive extraction classified technology background for James Culverwell as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T07:20:49.393917+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"QNRX 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","published_at":"2026-03-26T00:00:00+00:00","last_checked_at":"2026-05-16T07:20:49.235673+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:james-culverwell","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Quoin Pharmaceuticals, Ltd.","organization_id":"quoin-pharmaceuticals-ltd"},"claim_text":"Director at Quoin Pharmaceuticals, Ltd. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/james-culverwell#profile","url":"https://registry.alpha.ac/people/james-culverwell","dateModified":"2026-05-16T07:20:49.178+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/james-culverwell#person","name":"James Culverwell","url":"https://registry.alpha.ac/people/james-culverwell","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Quoin Pharmaceuticals, Ltd.","tickerSymbol":"NASDAQ: QNRX"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Quoin Pharmaceuticals, Ltd.","url":"https://registry.alpha.ac/companies/quoin-pharmaceuticals-ltd","tickerSymbol":"NASDAQ: QNRX"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925068650/tm252555-3_def14a.htm","name":"QNRX DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1671502/000110465926035251/qnrx-20251231x10k.htm","name":"QNRX 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/james-culverwell"},"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"d751713988987e9331980363e24189ce","subject":"alpha:person:james-culverwell","as_of":"2026-10-21T23:23:56.095099+00:00","recorded_at":"2026-10-21T23:23:56.095099+00:00","availability":"available","records":[],"next_offset":null,"limitations":["Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage."]},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":2,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":13,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[{"claim_type":"technology_background","kind":"extraction_disagreement","headline":false,"review_route":"internal_review","values":["false","true"],"publishers":["SEC EDGAR"],"source_types":["sec_filing"],"rationale":"Pipeline extraction runs disagree over documents from one publisher; routed to internal review, not headlined."}],"conflict_count":1,"headline_conflict_count":0,"internal_review_conflict_count":1,"contradiction_types":["technology_background"],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":2,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":13,"corroborated_claims":2,"sources":4,"distinct_sources":2,"role_claims":1,"last_reviewed_at":"2026-05-16T07:20:49.178+00:00","observed_at":"2026-10-21T23:23:55.70284+00:00","freshness_days":159}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"james-culverwell","canonical_url":"https://registry.alpha.ac/people/james-culverwell"},"publication":{"published_at":"2026-09-02T02:37:24.239523+00:00","last_reviewed_at":"2026-05-16T07:20:49.178+00:00","as_of":"2026-10-21T23:23:55.70284+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/james-culverwell","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/james-culverwell","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/james-culverwell.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}